-
1
-
-
0023001772
-
Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
-
Canner PL, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986;8(6):1245-1255.
-
(1986)
J Am Coll Cardiol
, vol.8
, Issue.6
, pp. 1245-1255
-
-
Canner, P.L.1
-
2
-
-
22644437126
-
Nicotinic acid: The broad-spectrum lipid drug. A 50th anniversary review
-
Carlson LA. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J Intern Med. 2005;258(2):94-114.
-
(2005)
J Intern Med
, vol.258
, Issue.2
, pp. 94-114
-
-
Carlson, L.A.1
-
5
-
-
68449089520
-
Nicotinic acid and the prevention of coronary artery disease
-
Digby JE, Lee JM, Choudhury RP. Nicotinic acid and the prevention of coronary artery disease. Curr Opin Lipidol. 2009;20(4):321-326.
-
(2009)
Curr Opin Lipidol
, vol.20
, Issue.4
, pp. 321-326
-
-
Digby, J.E.1
Lee, J.M.2
Choudhury, R.P.3
-
6
-
-
41049090772
-
Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk
-
Brown BG, Zhao XQ. Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk. Am J Cardiol. 2008;101(8A):58B-62B.
-
(2008)
Am J Cardiol
, vol.101
, Issue.8 A
-
-
Brown, B.G.1
Zhao, X.Q.2
-
7
-
-
68949215867
-
The mechanism and mitigation of niacin-induced flushing
-
Kamanna VS, Ganji SH, Kashyap ML. The mechanism and mitigation of niacin-induced flushing. Int J Clin Pract. 2009;63(9):1369-1377.
-
(2009)
Int J Clin Pract
, vol.63
, Issue.9
, pp. 1369-1377
-
-
Kamanna, V.S.1
Ganji, S.H.2
Kashyap, M.L.3
-
8
-
-
41149170003
-
Niacin use and cutaneous flushing: Mechanisms and strategies for prevention
-
Davidson MH. Niacin use and cutaneous flushing: mechanisms and strategies for prevention. Am J Cardiol. 2008;101(8A):14B-19B.
-
(2008)
Am J Cardiol
, vol.101
, Issue.8 A
-
-
Davidson, M.H.1
-
9
-
-
0346124307
-
The use of nicotinic acid in the treatment of pellagra
-
Spies TD, Cooper C, Blankenhorn MA. The use of nicotinic acid in the treatment of pellagra. JAMA. 1938;110(9):622-627.
-
(1938)
JAMA
, vol.110
, Issue.9
, pp. 622-627
-
-
Spies, T.D.1
Cooper, C.2
Blankenhorn, M.A.3
-
11
-
-
31044455384
-
The vasodilating effects of nicotinic acid (Relation to metabolic rate and body temperature)
-
Goldsmith GA, Cordill S. The vasodilating effects of nicotinic acid (Relation to metabolic rate and body temperature). Am J Med Sci. 1943;205(2):204-208.
-
(1943)
Am J Med Sci
, vol.205
, Issue.2
, pp. 204-208
-
-
Goldsmith, G.A.1
Cordill, S.2
-
12
-
-
31044448925
-
GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing
-
Benyo Z, et al. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest. 2005;115(12):3634-3640.
-
(2005)
J Clin Invest
, vol.115
, Issue.12
, pp. 3634-3640
-
-
Benyo, Z.1
-
13
-
-
0017399822
-
Studies on the mechanism of flush induced by nicotinic acid
-
Andersson RG, Aberg G, Brattsand R, Ericsson E, Lundholm L. Studies on the mechanism of flush induced by nicotinic acid. Acta Pharmacol Toxicol (Copenh). 1977;41(1):1-10. (Pubitemid 8150983)
-
(1977)
Acta Pharmacologica et Toxicologica
, vol.41
, Issue.1
, pp. 1-10
-
-
Andersson, R.G.G.1
Aberg, G.2
Brattsand, R.3
-
14
-
-
0018728611
-
Prostaglandins contribute to the vasodilation induced by nicotinic acid
-
Eklund B, Kaijser L, Nowak J, Wennmalm A. Prostaglandins contribute to the vasodilation induced by nicotinic acid. Prostaglandins. 1979;17(6):821-830.
-
(1979)
Prostaglandins
, vol.17
, Issue.6
, pp. 821-830
-
-
Eklund, B.1
Kaijser, L.2
Nowak, J.3
Wennmalm, A.4
-
15
-
-
0018747350
-
Dissociation of the effects of nicotinic acid on vasodilatation and lipolysis by a prostaglandin synthesis inhibitor, indomethacin, in man
-
Kaijser L, Eklund B, Olsson AG, Carlson LA. Dissociation of the effects of nicotinic acid on vasodilatation and lipolysis by a prostaglandin synthesis inhibitor, indomethacin, in man. Med Biol. 1979;57(2):114-117.
-
(1979)
Med Biol
, vol.57
, Issue.2
, pp. 114-117
-
-
Kaijser, L.1
Eklund, B.2
Olsson, A.G.3
Carlson, L.A.4
-
16
-
-
0024335924
-
Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid
-
Morrow JD, Parsons WG 3rd, Roberts LJ 2nd. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins. 1989; 38(2):263-274.
-
(1989)
Prostaglandins
, vol.38
, Issue.2
, pp. 263-274
-
-
Morrow, J.D.1
Parsons III, W.G.2
Roberts II, L.J.3
-
17
-
-
0025781643
-
Tolerance to nicotinic acid flushing
-
Stern RH, Spence JD, Freeman DJ, Parbtani A. Tolerance to nicotinic acid flushing. Clin Pharmacol Ther. 1991;50(1):66-70.
-
(1991)
Clin Pharmacol Ther
, vol.50
, Issue.1
, pp. 66-70
-
-
Stern, R.H.1
Spence, J.D.2
Freeman, D.J.3
Parbtani, A.4
-
18
-
-
33646258753
-
Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans
-
Cheng K, et al. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci U S A. 2006;103(17):6682-6687.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, Issue.17
, pp. 6682-6687
-
-
Cheng, K.1
-
19
-
-
41949100903
-
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia
-
Paolini JF, et al. Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia. Am J Cardiol. 2008;101(5):625-630.
-
(2008)
Am J Cardiol
, vol.101
, Issue.5
, pp. 625-630
-
-
Paolini, J.F.1
-
20
-
-
73849123857
-
What's the deal with niacin development: Is laropiprant add-on therapy a winning strategy to beat a straight flush?
-
Bays HE, Ballantyne C. What's the deal with niacin development: is laropiprant add-on therapy a winning strategy to beat a straight flush? Curr Opin Lipidol. 2009;20(6):467-476.
-
(2009)
Curr Opin Lipidol
, vol.20
, Issue.6
, pp. 467-476
-
-
Bays, H.E.1
Ballantyne, C.2
-
21
-
-
68949083513
-
Extended-release niacin (nicotinic acid)/ laropiprant
-
Perry CM. Extended-release niacin (nicotinic acid)/ laropiprant. Drugs. 2009;69(12):1665-1679.
-
(2009)
Drugs
, vol.69
, Issue.12
, pp. 1665-1679
-
-
Perry, C.M.1
-
22
-
-
33751087034
-
Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells
-
Benyo Z, Gille A, Bennett CL, Clausen BE, Offermanns S. Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. Mol Pharmacol. 2006;70(6):1844-1849.
-
(2006)
Mol Pharmacol
, vol.70
, Issue.6
, pp. 1844-1849
-
-
Benyo, Z.1
Gille, A.2
Bennett, C.L.3
Clausen, B.E.4
Offermanns, S.5
-
23
-
-
33751090692
-
Langerhans cells release prostaglandin D2 in response to nicotinic acid
-
Maciejewski-Lenoir D, Richman JG, Hakak Y, Gaidarov I, Behan DP, Connolly DT. Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol. 2006;126(12):2637-2646.
-
(2006)
J Invest Dermatol
, vol.126
, Issue.12
, pp. 2637-2646
-
-
Maciejewski-Lenoir, D.1
Richman, J.G.2
Hakak, Y.3
Gaidarov, I.4
Behan, D.P.5
Connolly, D.T.6
-
25
-
-
51649111846
-
The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist
-
Tang H, Lu JY, Zheng X, Yang Y, Reagan JD. The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist. Biochem Biophys Res Commun. 2008;375(4):562-565.
-
(2008)
Biochem Biophys Res Commun
, vol.375
, Issue.4
, pp. 562-565
-
-
Tang, H.1
Lu, J.Y.2
Zheng, X.3
Yang, Y.4
Reagan, J.D.5
-
26
-
-
22344443257
-
Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity
-
Bennett CL, et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol. 2005;169(4):569-576.
-
(2005)
J Cell Biol
, vol.169
, Issue.4
, pp. 569-576
-
-
Bennett, C.L.1
-
27
-
-
0034629473
-
The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models
-
Ochi T, Motoyama Y, Goto T. The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models. Eur J Pharmacol. 2000;391(1-2):49-54.
-
(2000)
Eur J Pharmacol
, vol.391
, Issue.1-2
, pp. 49-54
-
-
Ochi, T.1
Motoyama, Y.2
Goto, T.3
-
28
-
-
0028089109
-
NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/ cyclooxygenase (COX-2) activity in vitro
-
Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/ cyclooxygenase (COX-2) activity in vitro. Prostaglandins. 1994;47(1):55-59.
-
(1994)
Prostaglandins
, vol.47
, Issue.1
, pp. 55-59
-
-
Futaki, N.1
Takahashi, S.2
Yokoyama, M.3
Arai, I.4
Higuchi, S.5
Otomo, S.6
-
29
-
-
0025283192
-
Acipimox stimulates skin blood flow by a cyclo-oxygenase- Dependent mechanism
-
Edlund A, Musatti L, Wennmalm A. Acipimox stimulates skin blood flow by a cyclo-oxygenase- dependent mechanism. Eur J Clin Pharmacol. 1990;39(1):37-41.
-
(1990)
Eur J Clin Pharmacol
, vol.39
, Issue.1
, pp. 37-41
-
-
Edlund, A.1
Musatti, L.2
Wennmalm, A.3
-
30
-
-
0037352280
-
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
-
Tunaru S, et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med. 2003;9(3):352-355.
-
(2003)
Nat Med
, vol.9
, Issue.3
, pp. 352-355
-
-
Tunaru, S.1
-
31
-
-
50249112614
-
3-(1H-tetrazol-5-yl)-1,4,5, 6-tetrahydro-cyclopentapyrazole (MK-0354): A partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice
-
Semple G, et al. 3-(1H-tetrazol-5-yl)-1,4,5, 6-tetrahydro- cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice. J Med Chem. 2008;51(16):5101-5108.
-
(2008)
J Med Chem
, vol.51
, Issue.16
, pp. 5101-5108
-
-
Semple, G.1
-
32
-
-
66449111715
-
Beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice
-
Walters RW, et al. beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J Clin Invest. 2009;119(5):1312-1321.
-
(2009)
J Clin Invest
, vol.119
, Issue.5
, pp. 1312-1321
-
-
Walters, R.W.1
-
33
-
-
0035666867
-
PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily
-
Schaub A, Futterer A, Pfeffer K. PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. Eur J Immunol. 2001; 31(12):3714-3725.
-
(2001)
Eur J Immunol
, vol.31
, Issue.12
, pp. 3714-3725
-
-
Schaub, A.1
Futterer, A.2
Pfeffer, K.3
-
34
-
-
0034703615
-
cDNA representational difference analysis of human neutrophils stimulated by GM-CSF
-
Yousefi S, Cooper PR, Mueck B, Potter SL, Jarai G. cDNA representational difference analysis of human neutrophils stimulated by GM-CSF. Biochem Biophys Res Commun. 2000;277(2):401-409.
-
(2000)
Biochem Biophys Res Commun
, vol.277
, Issue.2
, pp. 401-409
-
-
Yousefi, S.1
Cooper, P.R.2
Mueck, B.3
Potter, S.L.4
Jarai, G.5
-
35
-
-
0037312490
-
Apoptosis by leukemia cell-targeted diphtheria toxin occurs via receptor-independent activation of Fas-associated death domain protein
-
Thorburn J, Frankel AE, Thorburn A. Apoptosis by leukemia cell-targeted diphtheria toxin occurs via receptor-independent activation of Fas-associated death domain protein. Clin Cancer Res. 2003;9(2):861-865.
-
(2003)
Clin Cancer Res
, vol.9
, Issue.2
, pp. 861-865
-
-
Thorburn, J.1
Frankel, A.E.2
Thorburn, A.3
-
36
-
-
0026670960
-
Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha
-
Morimoto H, Bonavida B. Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. J Immunol. 1992; 149(6):2089-2094.
-
(1992)
J Immunol
, vol.149
, Issue.6
, pp. 2089-2094
-
-
Morimoto, H.1
Bonavida, B.2
-
37
-
-
0345337249
-
Localization of prostaglandin-H synthase-1 and -2 in mouse skin: Implications for cutaneous function
-
Muller-Decker K, Scholz K, Neufang G, Marks F, Furstenberger G. Localization of prostaglandin-H synthase-1 and -2 in mouse skin: implications for cutaneous function. Exp Cell Res. 1998;242(1):84-91.
-
(1998)
Exp Cell Res
, vol.242
, Issue.1
, pp. 84-91
-
-
Muller-Decker, K.1
Scholz, K.2
Neufang, G.3
Marks, F.4
Furstenberger, G.5
-
38
-
-
0033791612
-
Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation
-
Wilgus TA, Ross MS, Parrett ML, Oberyszyn TM. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. Prostaglandins Other Lipid Mediat. 2000;62(4):367-384.
-
(2000)
Prostaglandins Other Lipid Mediat
, vol.62
, Issue.4
, pp. 367-384
-
-
Wilgus, T.A.1
Ross, M.S.2
Parrett, M.L.3
Oberyszyn, T.M.4
-
39
-
-
1342268323
-
Genetic deficiency or pharmacological inhibition of cyclooxygenase-1 or -2 induces mouse keratinocyte differentiation in vitro and in vivo
-
Akunda JK, Lao HC, Lee CA, Sessoms AR, Slade RM, Langenbach R. Genetic deficiency or pharmacological inhibition of cyclooxygenase-1 or -2 induces mouse keratinocyte differentiation in vitro and in vivo. FASEB J. 2004;18(1):185-187.
-
(2004)
FASEB J
, vol.18
, Issue.1
, pp. 185-187
-
-
Akunda, J.K.1
Lao, H.C.2
Lee, C.A.3
Sessoms, A.R.4
Slade, R.M.5
Langenbach, R.6
-
40
-
-
0029932386
-
Cyclooxygenases in human and mouse skin and cultured human keratinocytes: Association of COX-2 expression with human keratinocyte differentiation
-
Leong J, Hughes-Fulford M, Rakhlin N, Habib A, Maclouf J, Goldyne ME. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp Cell Res. 1996;224(1):79-87.
-
(1996)
Exp Cell Res
, vol.224
, Issue.1
, pp. 79-87
-
-
Leong, J.1
Hughes-Fulford, M.2
Rakhlin, N.3
Habib, A.4
Maclouf, J.5
Goldyne, M.E.6
-
41
-
-
0022597999
-
Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis
-
Pentland AP, Needleman P. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J Clin Invest. 1986;77(1):246-251.
-
(1986)
J Clin Invest
, vol.77
, Issue.1
, pp. 246-251
-
-
Pentland, A.P.1
Needleman, P.2
-
42
-
-
0015342727
-
Biosynthesis and metabolism of prostaglandin e 2 in human skin
-
Jonsson CE, Anggard E. Biosynthesis and metabolism of prostaglandin E 2 in human skin. Scand J Clin Lab Invest. 1972;29(3):289-296.
-
(1972)
Scand J Clin Lab Invest
, vol.29
, Issue.3
, pp. 289-296
-
-
Jonsson, C.E.1
Anggard, E.2
-
43
-
-
0017770145
-
Role of prostaglandin-mediated vasodilatation in inflammation
-
Williams TJ, Peck MJ. Role of prostaglandin-mediated vasodilatation in inflammation. Nature. 1977;270(5637):530-532.
-
(1977)
Nature
, vol.270
, Issue.5637
, pp. 530-532
-
-
Williams, T.J.1
Peck, M.J.2
-
44
-
-
0025310785
-
Comparison of eicosanoid generation by highly purified human Langerhans cells and keratinocytes
-
Rosenbach T, Czernielewski J, Hecker M, Czarnetzki B. Comparison of eicosanoid generation by highly purified human Langerhans cells and keratinocytes. J Invest Dermatol. 1990;95(1):104-107.
-
(1990)
J Invest Dermatol
, vol.95
, Issue.1
, pp. 104-107
-
-
Rosenbach, T.1
Czernielewski, J.2
Hecker, M.3
Czarnetzki, B.4
-
45
-
-
0023907782
-
Characterization and distribution of prostaglandin D synthetase in rat skin
-
Ujihara M, Horiguchi Y, Ikai K, Urade Y. Characterization and distribution of prostaglandin D synthetase in rat skin. J Invest Dermatol. 1988;90(4):448-451.
-
(1988)
J Invest Dermatol
, vol.90
, Issue.4
, pp. 448-451
-
-
Ujihara, M.1
Horiguchi, Y.2
Ikai, K.3
Urade, Y.4
-
46
-
-
63849228890
-
Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms
-
Dishy V, et al. Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms. J Clin Pharmacol. 2009;49(4):416-422.
-
(2009)
J Clin Pharmacol
, vol.49
, Issue.4
, pp. 416-422
-
-
Dishy, V.1
-
47
-
-
0021163545
-
Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase
-
Pedersen AK, FitzGerald GA. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. N Engl J Med. 1984;311(19):1206-1211.
-
(1984)
N Engl J Med
, vol.311
, Issue.19
, pp. 1206-1211
-
-
Pedersen, A.K.1
FitzGerald, G.A.2
-
48
-
-
0023259345
-
Pharmacokinetics of enteric-coated aspirin and inhibition of platelet thromboxane A2 and vascular prostacyclin generation in humans
-
Cerletti C, et al. Pharmacokinetics of enteric-coated aspirin and inhibition of platelet thromboxane A2 and vascular prostacyclin generation in humans. Clin Pharmacol Ther. 1987;42(2):175-180.
-
(1987)
Clin Pharmacol Ther
, vol.42
, Issue.2
, pp. 175-180
-
-
Cerletti, C.1
-
49
-
-
0027146692
-
Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
-
Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993;90(24):11693-11697.
-
(1993)
Proc Natl Acad Sci U S A
, vol.90
, Issue.24
, pp. 11693-11697
-
-
Mitchell, J.A.1
Akarasereenont, P.2
Thiemermann, C.3
Flower, R.J.4
Vane, J.R.5
-
51
-
-
38049017120
-
G12-G13-LARG-mediated signaling in vascular smooth muscle is required for saltinduced hypertension
-
Wirth A, et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for saltinduced hypertension. Nat Med. 2008;14(1):64-68.
-
(2008)
Nat Med
, vol.14
, Issue.1
, pp. 64-68
-
-
Wirth, A.1
-
52
-
-
0033559118
-
Rapid modification of bacterial artificial chromosomes by ET-recombination
-
Muyrers JP, Zhang Y, Testa G, Stewart AF. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res. 1999; 27(6):1555-1557.
-
(1999)
Nucleic Acids Res
, vol.27
, Issue.6
, pp. 1555-1557
-
-
Muyrers, J.P.1
Zhang, Y.2
Testa, G.3
Stewart, A.F.4
-
53
-
-
0345708272
-
G13 is an essential mediator of platelet activation in hemostasis and thrombosis
-
Moers A, et al. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med. 2003;9(11):1418-1422.
-
(2003)
Nat Med
, vol.9
, Issue.11
, pp. 1418-1422
-
-
Moers, A.1
-
54
-
-
43149084824
-
Isolation and shortterm culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice
-
Lichti U, Anders J, Yuspa SH. Isolation and shortterm culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat Protoc. 2008;3(5):799-810.
-
(2008)
Nat Protoc
, vol.3
, Issue.5
, pp. 799-810
-
-
Lichti, U.1
Anders, J.2
Yuspa, S.H.3
-
55
-
-
0034691150
-
Chimeric green fluorescent protein-aequorin as bioluminescent Ca2+ reporters at the single-cell level
-
Baubet V, Le Mouellic H, Campbell AK, Lucas- Meunier E, Fossier P, Brulet P. Chimeric green fluorescent protein-aequorin as bioluminescent Ca2+ reporters at the single-cell level. Proc Natl Acad Sci U S A. 2000;97(13):7260-7265.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, Issue.13
, pp. 7260-7265
-
-
Baubet, V.1
Le Mouellic, H.2
Campbell, A.K.3
Lucas-Meunier, E.4
Fossier, P.5
Brulet, P.6
|